AREV Life Sciences Global Corp. AREVF

Company Overview

AREV Life Sciences Global Corp. is a Canadian life sciences and biotechnology company focused on the development and commercialization of proprietary extraction technologies, therapeutic compounds, and nutritional products. The company has historically operated in the cannabinoid, functional ingredient, and pharmaceutical research sectors, with activities spanning extraction science, clinical-stage therapeutics, and wellness product development. AREV has traded publicly in Canada and the United States under the ticker AREVF and has positioned itself around alternative medicine research and bioactive ingredient commercialization.

The company’s primary business activities have included the development of extraction methodologies for cannabinoids and other plant-based compounds, alongside efforts to advance therapeutic candidates targeting areas such as oncology and viral diseases. AREV has also pursued opportunities in consumer health and wellness markets through formulations involving functional ingredients and nutraceutical applications. Public disclosures and corporate materials indicate that the company evolved from an extraction-technology and cannabis-focused enterprise into a broader life sciences platform emphasizing pharmaceutical research collaborations and intellectual property development. Certain operational and commercialization details vary across public disclosures, and some historical business lines appear to have shifted over time based on available filings.